Therapeutic inertia: Underdiagnosed and undertreated hypertension in children participating in the T1D Exchange Clinic Registry

Pediatric Diabetes

Volumn 17, Issue 1, 2016, Pages 15-20

  Nambam, Bimota ^a   Dubose, Stephanie N ^b   Nathan, Brandon M ^c   Beck, Roy W ^b   Maahs, David M ^d   Wadwa, R Paul ^d   Tamborlane, William V ^e   Foster, Nicole C ^b   Miller, Kellee M ^b   Haller, Michael J ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b JAEB CENTER FOR HEALTH RESEARCH   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF COLORADO DENVER   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Complications of diabetes mellitus; Diagnosis; Hypertension; Type 1 diabetes mellitus

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; ANTIHYPERTENSIVE AGENT;

ADOLESCENT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BODY MASS; CHILD; DISEASE REGISTRY; ELEVATED BLOOD PRESSURE; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; UNITED STATES; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM EXAMINATION; CLINICAL TRIAL; COMPLICATION; MULTICENTER STUDY; PHYSIOLOGY; PRESCHOOL CHILD; PROGNOSIS; REGISTER; RETROSPECTIVE STUDY; RISK FACTOR; TIME FACTOR;

ADOLESCENT; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; PROGNOSIS; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 84953212281     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/pedi.12231     Document Type: Article

References (25)

1. Epstein M, Sowers JR. Diabetes mellitus and hypertension. Hypertension 1992: 19: 403-418.
2. Hovind P, Tarnow L, Rossing P et al. Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study. BMJ 2004: 328: 1105.
3. Klein R, Klein BE, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology 1998: 105: 1801-1815.
4. Orchard TJ, Costacou T, Kretowski A, Nesto RW. Type 1 diabetes and coronary artery disease. Diabetes Care 2006: 29: 2528-2538.
5. Orchard TJ, Olson JC, Erbey JR et al. Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care 2003: 26: 1374-1379.
6. Soedamah-Muthu SS, Chaturvedi N, Toeller M et al. Risk factors for coronary heart disease in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study. Diabetes Care 2004: 27: 530-537.
7. Miller RG, Secrest AM, Ellis D, Becker DJ, Orchard TJ. Changing impact of modifiable risk factors on the incidence of major outcomes of type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care 2013: 36: 3999-4006.
8. Secrest AM, Becker DJ, Kelsey SF, Laporte RE, Orchard TJ. Cause-specific mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes. Diabetes 2010: 59: 3216-3222.
9. Skrivarhaug T, Bangstad HJ, Stene LC, Sandvik L, Hanssen KF, Joner G. Long-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway. Diabetologia 2006: 49: 298-305.
10. Orchard TJ, Forrest KY, Kuller LH, Becker DJ. Lipid and blood pressure treatment goals for type 1 diabetes: 10-year incidence data from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care 2001: 24: 1053-1059.
11. Berenson GS. Childhood risk factors predict adult risk associated with subclinical cardiovascular disease: the Bogalusa Heart Study. Am J Cardiol 2002: 90: 3L-7L.
12. Eppens MC, Craig ME, Cusumano J et al. Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes. Diabetes Care 2006: 29: 1300-1306.
13. Margeirsdottir HD, Larsen JR, Brunborg C, Overby NC, Dahl-Jorgensen K. High prevalence of cardiovascular risk factors in children and adolescents with type 1 diabetes: a population-based study. Diabetologia 2008: 51: 554-561.
14. Rodriguez BL, Dabelea D, Liese AD et al. Prevalence and correlates of elevated blood pressure in youth with diabetes mellitus: the SEARCH for diabetes in youth study. J Pediatr 2010; 157:245.e1-251.e1 .
15. Schwab KO, Doerfer J, Hecker W et al. Spectrum and prevalence of atherogenic risk factors in 27, 358 children, adolescents, and young adults with type 1 diabetes: cross-sectional data from the German diabetes documentation and quality management system (DPV). Diabetes Care 2006: 29: 218-225.
16. Sun SS, Grave GD, Siervogel RM, Pickoff AA, Arslanian SS, Daniels SR. Systolic blood pressure in childhood predicts hypertension and metabolic syndrome later in life. Pediatrics 2007: 119: 237-246.
17. National Heart, Lung, and Blood Institute. Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents. Bethesda, MD: National Heart, Lung, and Blood Institute, 2005.
18. American Diabetes Association. Standards of medical care in diabetes-2014. Diabetes Care 2014: 37 (Suppl. 1): S14-S80.
19. Beck RW, Tamborlane WV, Bergenstal RM, Miller KM, Dubose SN, Hall CA. The T1D Exchange Clinic Registry. J Clin Endocrinol Metab 2012: 97: 4383-4389.
20. Centers for Disease Control and Prevention. Z-score data files 2013 (available from http://www.cdc.gov/growthcharts/zscore.htm).
21. Ceriello A. Controlling oxidative stress as a novel molecular approach to protecting the vascular wall in diabetes. Curr Opin Lipidol 2006: 17: 510-518.
22. de Boer IH, Kestenbaum B, Rue TC et al. Insulin therapy, hyperglycemia, and hypertension in type 1 diabetes mellitus. Arch Intern Med 2008: 168: 1867-1873.
23. Stabouli S, Kotsis V, Rizos Z et al. Left ventricular mass in normotensive, prehypertensive and hypertensive children and adolescents. Pediatr Nephrol 2009: 24: 1545-1551.
24. Urbina EM, Khoury PR, McCoy C, Daniels SR, Kimball TR, Dolan LM. Cardiac and vascular consequences of pre-hypertension in youth. J Clin Hypertens (Greenwich) 2011: 13: 332-342.
25. Drukteinis JS, Roman MJ, Fabsitz RR et al. Cardiac and systemic hemodynamic characteristics of hypertension and prehypertension in adolescents and young adults: the Strong Heart Study. Circulation 2007: 115: 221-227.